Idexx Laboratories, Inc. (IDXX)

Stay up to date

idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an

Financial Statements

Key Info

Industry: In-Vitro Diagnostic Substance Manufacturing
Sector: Manufacturing
CEO Name: Jonathan Jay Mazelsky

Key Statistics

Stock Price: $437.27
Dividend Yield: 0%
Market Capitalization: $36,293,410,000
Shares Outstanding: 83,000,000
Number of Employees: 7,962
Trailing 12-Month EPS: $9.42
Trailing 12-Month DPS: $0
Payout Ratio: 0.0%

Important Dates

Next Earnings Date: 2023-10-31
Next Ex-Dividend Date:

Price Trends

Current Stock Price: $437.27
52-week high: $564.74
52-week low: $317.06
200-day moving average: $488.5
50-day moving average: $474.55

Performance

1-Month Price Return: -14.5%
3-Month Price Return: -11.6%
6-Month Price Return: -10.3%
1-Year Price Return: 31.8%
2-Year Price Return: -30.5%
5-Year Price Return: 75.1%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast